SYRE   $42.42  0.26% Market Open

Spyre Therapeutics, Inc.

EMA (20): 2026-02-05 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2025-10-08 the price crossed up the moving average line and demonstrates an upside trend.

EMA (100): 2025-10-08 the price crossed up the moving average line and demonstrates an upside trend.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 27.38%
EMA (20) date of signal Feb. 5, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 137.33%
EMA (50) date of signal Oct. 8, 2025, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 137.33%
EMA (100) date of signal Oct. 8, 2025, 3 a.m.
RSI Signals bullish recovery
RSI (14) Yield 0.0
RSI (14) date of signal March 4, 2026, 3 a.m.
MACD Signals bearish reversal
MACD Yield 4.72%
MACD date of signal March 3, 2026, 3 a.m.
Stochastic Signals bearish weakening
Stochastic Yield 0.0
Stochastic date of signal March 4, 2026, 3 a.m.
Updated March 4, 2026, 8:55 p.m.